The federal judge overseeing hundreds of Pradaxa internal bleeding lawsuits that have been consolidated before him is making encouraging comments about the progress of the case.
Legal experts said that normally such progress indicates that settlements — in which victims agree to resolve their cases while being compensated for their claims — may be in the near future.
These experts also said that even though the judge is expressing satisfaction that the cases are moving forward there is still time for other Pradaxa bleeding victims who have not filed an action to come forth.
Pradaxa internal bleeding lawyers are still offering free consultations to victims who took the blood thinner to prevent blood clots and life-threatening health problems.
However, the fact that there may be legal time limits affecting eligibility and the possibility that the entire litigation may wind up in a settlement means that those wishing to file a Pradaxa lawsuit should seek legal help sooner rather than later.
Here are some of the most frequently asked questions from Pradaxa victims:
- How do I file a claim or lawsuit over Pradaxa?
- Am I eligible to file a claim or lawsuit?
- How many other Pradaxa lawsuits have been filed?
- I am no longer taking Pradaxa, am I still eligible?
- Besides my medical costs what other damages am I eligible for?
- Do most Pradaxa cases settle or go to trial?
- Is there a time limit for a Pradaxa case to be filed?
These Pradaxa internal bleeding lawsuits document claims by victims who have claim to have suffered internal bleeding that led to strokes, hemorrhages, kidney failure, liver failure and other serious health problems.
News media reports show that while Pradaxa was a huge commercial success, generating billions of dollars in sales, it also has been linked to hundreds of deaths and thousands of “adverse event reports” to the U.S. Food and Drug Administration.
Chief Judge David Herndon of the U.S. District Court for the Southern District of Illinois, is the federal judge presiding over the Pradaxa multi-district litigation, in which lawsuits from across the country have been consolidated since last year.
News reports out of Illinois quoted Herndon as saying that there have been no setbacks in the proceedings and that attorneys for the plaintiffs and Pradaxa’s German manufacturer Boehringer Ingelheim have exchanged tens of thousands of documents.
The judge said that he anticipates lawyers for the victims to soon be taking depositions, or pre-trial questioning, of Boehringer Ingelheim officials.
“We’re really starting now to get to the meat of the litigation,” Herndon was quoted as saying. “The pace is picking up more.”
Court documents show that there are now at least 176 member cases and 192 plaintiffs in the multi-district litigation in addition to other Pradaxa lawsuits that are now pending in state courts across the country.